<DOC>
	<DOC>NCT02568319</DOC>
	<brief_summary>This is a multi-center, randomized, placebo-controlled, double-blind study evaluating the safety and efficacy of LIPO-202 for the reduction of central abdominal bulging in obese subjects.</brief_summary>
	<brief_title>Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male or nonpregnant female subjects Capable of providing written consent BMI &gt; 30 kg/m2 but &lt; 40 kg/m2 Stable diet and exercise routine At least "Slightly Dissatisfied" with their abdominal bulging on the Abdominal Contour Questionnaire (ACQ) BMI &gt; 40 kg/m2 Have had any treatment of the fat around your abdomen, including surgical procedures (tummy tuck, liposuction), injections for fat loss or treatments with devices to reduce fat in your abdomen. Plan on starting a weight loss or exercise program during the study Known hypersensitivity to study drugs Have any medical condition that might complicate study procedures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>